Penalization therapy for unilateral amblyopia

Unilateral amblyopia is a neurodevelopmental disorder of the visual system characterized by reduced best-corrected visual acuity in one eye that cannot be attributed directly to a structural ocular abnormality Arising during early childhood when the visual cortex exhibits critical plasticity, it is typically caused by abnormal binocular visual experience due to strabismus, anisometropia, or physical visual deprivation This disrupted binocular input leads to cortical suppression of the affected e...

Arising during early childhood when the visual cortex exhibits critical plasticity, it is typically caused by abnormal binocular visual experience due to strabismus, anisometropia, or physical visual deprivation Penalization therapy represents an interventional approach for this condition that intentionally blurs or degrades vision in the dominant, non-amblyopic eye—most commonly through cycloplegic agents such as atropine or optical defocusing—to promote neuroplastic recovery and force visual p...

Arising during early childhood when the visual cortex exhibits critical plasticity, it is typically caused by abnormal binocular visual experience due to strabismus, anisometropia, or physical visual deprivation Penalization therapy represents an interventional approach for this condition that intentionally blurs or degrades vision in the dominant, non-amblyopic eye—most commonly through cycloplegic agents such as atropine or optical defocusing—to promote neuroplastic recovery and force visual p...

Arising during early childhood when the visual cortex exhibits critical plasticity, it is typically caused by abnormal binocular visual experience due to strabismus, anisometropia, or physical visual deprivation This disrupted binocular input leads to cortical suppression of the affected eye and maladaptive synaptic development within the lateral geniculate nucleus and primary visual cortex

Penalization therapy represents an interventional approach for this condition that intentionally blurs or degrades vision in the dominant, non-amblyopic eye—most commonly through cycloplegic agents such as atropine or optical defocusing—to promote neuroplastic recovery and force visual processing through the amblyopic eye